131 related articles for article (PubMed ID: 33447731)
1. Comparison between hyaluronic acid filler and botulinum toxin type A in the treatment of thyroid upper eyelid retraction.
Hassan Hussien M; Abd El-Wahed Hassan E; El-Haddad NSEM
Ther Adv Ophthalmol; 2020; 12():2515841420979113. PubMed ID: 33447731
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid gel injection for dysthyroid upper eyelid retraction in Asian patients.
Young SM; Kim JH; Kim YD; Karnsiritanont V; Lang SS; Woo KI
Orbit; 2023 Aug; 42(4):389-396. PubMed ID: 36082627
[TBL] [Abstract][Full Text] [Related]
3. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a for dysthyroid upper eyelid retraction.
Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
[TBL] [Abstract][Full Text] [Related]
5. An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results.
Ozturk Karabulut G; Fazil K; Saracoglu Yilmaz B; Ozturker C; Günaydın ZK; Taskapili M; Kaynak P
Orbit; 2021 Oct; 40(5):381-388. PubMed ID: 32885692
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Levator-Muller's Complex Thickness on Ultrasound Biomicroscopy to Botulinum Toxin A Injection in Thyroid-Related Upper Eyelid Retraction.
Kandasamy S; Agrawal S; Pushker N; Meel R; Bajaj MS; Thirumurthy V; Jyotsna VP
J Ultrasound Med; 2023 Feb; 42(2):399-408. PubMed ID: 35546328
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation.
Kohn JC; Rootman DB; Liu W; Goh AS; Hwang CJ; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2014; 30(5):400-4. PubMed ID: 24833450
[TBL] [Abstract][Full Text] [Related]
8. Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler.
Mancini R; Khadavi NM; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2011; 27(1):1-3. PubMed ID: 20551854
[TBL] [Abstract][Full Text] [Related]
9. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection.
Uddin JM; Davies PD
Ophthalmology; 2002 Jun; 109(6):1183-7. PubMed ID: 12045064
[TBL] [Abstract][Full Text] [Related]
10. Early experimental results of using a novel delivery carrier, hyaluronan-phosphatidylethanolamine (HA-PE), which may allow simple bladder instillation of botulinum toxin A as effectively as direct detrusor muscle injection.
El Shatoury MG; DeYoung L; Turley E; Yazdani A; Dave S
J Pediatr Urol; 2018 Apr; 14(2):172.e1-172.e6. PubMed ID: 29482891
[TBL] [Abstract][Full Text] [Related]
11. A Comparison Between Hyaluronic Acid and Polylactic Acid Filler Injections for Temporary Penile Augmentation in Patients with Small Penis Syndrome: A Multicenter, Patient/Evaluator-Blind, Comparative, Randomized Trial.
Yang DY; Jeong HC; Ahn ST; Bae WJ; Moon DG; Kim SW; Lee WK
J Sex Med; 2020 Jan; 17(1):133-141. PubMed ID: 31735613
[TBL] [Abstract][Full Text] [Related]
12. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.
Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823
[TBL] [Abstract][Full Text] [Related]
13. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy].
Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335
[No Abstract] [Full Text] [Related]
14. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.
Lee JM; Lee H; Park M; Baek S
J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303
[TBL] [Abstract][Full Text] [Related]
15. [Morphometric analysis of eyelid fissure in patients with eyelid retraction in acute stage of dysthyroid orbitopathy after treatment with botulinum toxin type A].
Costa PG; Saraiva FP; Pereira IC; Matayoshi S
Arq Bras Oftalmol; 2008; 71(4):480-5. PubMed ID: 18797654
[TBL] [Abstract][Full Text] [Related]
16. The Injection for the Lower Eyelid Retraction: A Mechanical Analysis of the Lifting Effect of the Hyaluronic Acid.
Xi W; Han S; Feng S; Li K; Brunetti B; Lazzeri D; Tong Y; Zhang Y
Aesthetic Plast Surg; 2019 Oct; 43(5):1310-1317. PubMed ID: 31399822
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of the Efficacy and Safety Between Hyaluronic Acid and Polylactic Acid Filler Injection in Penile Augmentation: A Multicenter, Patient/Evaluator-Blinded, Randomized Trial.
Yang DY; Ko K; Lee SH; Lee WK
J Sex Med; 2019 Apr; 16(4):577-585. PubMed ID: 30833149
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of lower eyelid epiblepharon by injection of botulinum toxin A in patients under two years of age.
Chen CY; Nava-Castaneda A
Nepal J Ophthalmol; 2013; 5(2):177-81. PubMed ID: 24172551
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease.
Olver JM
Br J Ophthalmol; 1998 May; 82(5):528-33. PubMed ID: 9713061
[TBL] [Abstract][Full Text] [Related]
20. Keratoconus progression is not inhibited by reducing eyelid muscular force with botulinum toxin A treatment: a randomized trial.
Renesto ADC; Osaki TH; Osaki MH; Hirai FE; Campos M
Arq Bras Oftalmol; 2017; 80(2):88-92. PubMed ID: 28591280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
